What Does Progesterone Do During Perimenopause?

Progesterone is the first reproductive hormone to decline in perimenopause — often years before oestrogen falls significantly. Its drop explains why women in their early-to-mid 40s start experiencing heavy periods, broken sleep, and anxiety without a clear cause. Understanding what progesterone does makes those symptoms far less confusing.

What does progesterone do?

Progesterone is a steroid hormone produced mainly by the corpus luteum — the temporary structure that forms in the ovary after an egg is released. It rises sharply in the second half of the menstrual cycle (the luteal phase) and falls if pregnancy does not occur.

Its four main roles in the body:

• Stabilises the uterine lining. Progesterone prevents the endometrium from growing unchecked. Without it, oestrogen drives continuous lining build-up, leading to heavy and prolonged periods.
• Promotes sleep. Progesterone is a natural sedative. It is metabolised into allopregnanolone, a neurosteroid that binds to GABA-A receptors in the brain — the same receptors targeted by benzodiazepines. Higher progesterone = calmer, deeper sleep.
• Reduces anxiety. Allopregnanolone also has direct anti-anxiety effects. Low progesterone means less allopregnanolone, which contributes to heightened anxiety and mood sensitivity.
• Counterbalances oestrogen. Oestrogen is stimulating and proliferative. Progesterone is its biological counterpart. The two hormones need to be in proportion for normal cycles and mood.

Why does progesterone fall first during perimenopause?

Progesterone falls first because its production depends entirely on ovulation.

Here is the sequence:

1. As women approach their mid-40s, ovarian follicles become less responsive to hormonal signals.
2. Ovulation becomes irregular — some cycles happen without a mature egg being released (anovulatory cycles).
3. No ovulation means no corpus luteum forms.
4. No corpus luteum means no progesterone is produced in that cycle.
5. Oestrogen, produced by the follicles themselves, continues — sometimes at normal or even elevated levels.

The result: oestrogen without progesterone to balance it. This is often called oestrogen dominance, and it is the defining hormonal state of early perimenopause.

Indian women reach menopause at an average age of 46–47 years — roughly two to three years earlier than the global average of 51. This means perimenopause and its progesterone-related symptoms often begin in the late 30s or early 40s. For more on the full hormonal picture of this transition, see our guide to perimenopause explained.

What happens when progesterone is low?

Low progesterone, with oestrogen still present, creates a specific cluster of symptoms:

Menstrual changes

• Heavier, longer periods
• Shorter cycles (cycle may shorten from 28 days to 21–24 days)
• Clotting
• Mid-cycle spotting

These happen because oestrogen builds up the uterine lining without progesterone to stabilise it. See more about irregular periods.

Sleep disruption

• Difficulty falling asleep
• Waking at 2–4am and being unable to return to sleep
• Light, unrefreshing sleep

Progesterone’s sedative effect via GABA-A is lost when levels drop. This is one of the earliest and most disruptive symptoms of perimenopause. Read more about sleep problems in perimenopause.

Anxiety and mood changes

• Generalised anxiety that feels disproportionate to life circumstances
• Irritability, particularly in the week before a period
• Low mood, tearfulness
• Racing thoughts at night

Allopregnanolone — the calming metabolite of progesterone — drops with progesterone. The GABAergic calming signal weakens. Many women describe feeling “wired but tired.” See our full symptom guide on anxiety.

Other symptoms

• Breast tenderness and swelling
• Bloating and water retention
• Headaches, particularly premenstrual
• Heightened sensitivity to oestrogen’s stimulating effects

What is body-identical progesterone and how is it different from synthetic progestins?

This distinction matters clinically.

Body-identical (micronised) progesterone is chemically identical to the progesterone the ovaries produce. Because it is metabolised into allopregnanolone, it retains the calming and sleep-promoting properties of natural progesterone.

Synthetic progestogens (progestins) — such as norethisterone, medroxyprogesterone acetate (MPA), and levonorgestrel — have a different molecular structure. They protect the uterus from oestrogen-driven overgrowth, but they do not convert to allopregnanolone. They do not provide the sleep or anti-anxiety benefit. Some progestins actively worsen mood in women who are sensitive to them.

For women in perimenopause who are struggling primarily with sleep and anxiety — and whose symptoms are driven by falling progesterone — body-identical micronised progesterone is the clinically preferred option.

Key difference at a glance:

What progesterone options are available in India?

Micronised progesterone is available by prescription in India. Ask your gynaecologist specifically for micronised progesterone capsules — not a synthetic progestin.

Indian brand names to ask about:

• Susten 200mg (Sun Pharma) — widely available, oral capsule
• Gestofit 200mg (Cipla) — oral capsule, also available as vaginal
• Lutein 200mg (Lupin) — oral capsule

These are typically prescribed as a 200mg capsule taken orally at night. Taking progesterone at night is intentional: the sedative effect of its conversion to allopregnanolone is used therapeutically to improve sleep.

Progesterone is not available over the counter in India for this purpose. It requires a gynaecologist’s prescription and appropriate evaluation — including a discussion of your cycle history, symptoms, and whether you need to protect the uterine lining if oestrogen therapy is also being considered.

How do I know if low progesterone is causing my symptoms?

There is no single definitive test. Blood progesterone levels fluctuate significantly across the cycle and across months in perimenopause.

Useful markers and approaches:

• Day 21 serum progesterone (or 7 days post-ovulation, if cycle length varies) — A mid-luteal progesterone above 30 nmol/L confirms ovulation. Values between 16–30 nmol/L suggest suboptimal ovulation. Values below 16 nmol/L indicate probable anovulation in that cycle.
• Symptom pattern: If symptoms worsen in the second half of the cycle (after ovulation) and ease with the period, low luteal-phase progesterone is a likely contributor
• Menstrual history: Cycles becoming shorter, heavier, or more irregular are a clinical indicator
• AMH (Anti-Müllerian Hormone): Low AMH suggests declining ovarian reserve, which correlates with less reliable ovulation

A single “normal” blood test does not rule out functional progesterone deficiency. Clinicians experienced in perimenopause assess symptoms alongside tests.

When should I talk to a doctor about progesterone?

Seek a gynaecological assessment if:

• Your periods have become significantly heavier, longer, or more irregular
• You are waking consistently between 2–4am without an obvious cause
• Anxiety has increased noticeably in the past 12–24 months without a clear trigger
• Premenstrual symptoms (mood, breast pain, bloating) have worsened
• You are over 38 and experiencing a combination of the above

You do not need to wait until periods stop to have this conversation. Perimenopause is diagnosable on symptoms alone — no blood test is required for diagnosis.

If you are unsure whether your symptoms point to progesterone, talk to our companion for a guided conversation, or take our symptom check to get a clearer picture of where you are in the perimenopausal transition.

Frequently Asked Questions

Can I take progesterone without taking oestrogen?

Yes. Progesterone can be prescribed on its own, without oestrogen. This is sometimes called progesterone-only HRT or progesterone monotherapy. It is an option for women in early perimenopause whose main symptoms are poor sleep, anxiety, and heavy periods — without significant hot flushes (which are more oestrogen-driven). Micronised progesterone 100–200mg taken at night has evidence for improving sleep quality and reducing anxiety in this group. It is not appropriate for everyone; your gynaecologist will assess whether it fits your symptom profile.

Does progesterone help with hot flushes?

Progesterone alone has a modest effect on hot flushes, but it is not as effective as oestrogen for vasomotor symptoms. Some research, including the Hitchcock and Prior studies, suggests that oral micronised progesterone can reduce hot flush frequency compared to placebo. For women who cannot take oestrogen, it may be worth discussing with a doctor. For most women, oestrogen remains the primary treatment for hot flushes, with progesterone added to protect the uterus.

Is the progesterone in the Mirena IUS (intrauterine system) the same as micronised progesterone?

No. The Mirena IUS (intrauterine system) contains levonorgestrel, a synthetic progestin. It is highly effective at protecting the uterine lining locally (within the uterus), which is why some specialists use it alongside systemic oestrogen as a HRT regimen. However, levonorgestrel does not convert to allopregnanolone. It does not provide the calming, sleep-promoting, or systemic anti-anxiety benefits of oral micronised progesterone. The two serve different purposes and are not interchangeable in terms of their effects on mood and sleep.

How long does it take for progesterone to improve sleep?

Many women notice an improvement in sleep within the first one to two weeks of taking oral micronised progesterone at night. The sedative effect is relatively rapid because it depends on the acute conversion of progesterone to allopregnanolone, not on a slow hormonal recalibration. Full benefit — including reduced nighttime waking — typically stabilises over four to six weeks. If sleep does not improve within six to eight weeks, the dose or formulation may need review.

Is progesterone safe to take long-term?

Body-identical micronised progesterone has a reassuring safety profile compared to synthetic progestins. The French E3N cohort study found a substantially lower breast cancer risk with micronised progesterone compared to synthetic progestins. The absolute risk compared to non-HRT users is small but remains an active area of research — the picture continues to evolve. Discuss your personal risk profile with your doctor. The current NICE menopause guideline (NG23) and the British Menopause Society support the use of body-identical progesterone as a safer progestogen option. Long-term use should still be reviewed annually with your gynaecologist, with a discussion of your individual risk factors. In India, this conversation is best had with a gynaecologist experienced in menopause medicine.